Search

Search Results
Results 19171 - 19180 of 19770 for Able-bodied
  • Copaxone Pen
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Copaxone Pen intended for persons living in Australia.
  • Copaxone 40mg/mL
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Copaxone 40mg/mL intended for persons living in Australia.
  • Navigating Insulin Pumps: Technology, Benefits, and What’s Next
    Health - 11 Dec 2024
    Understanding insulin pumps: key components, benefits, and advancements in technology for effective diabetes management and improved quality of life.
  • Bexsero
    Drug - 6 Dec 2024
    Consumer Medicine Information (CMI) about Bexsero intended for persons living in Australia.
  • Exploring coronary flow reserve measurement
    White Paper - 6 Dec 2024
    Coronary flow reserve (CFR) is an important indicator of coronary artery disease and how the coronary arteries adapt to certain physiological conditions.
  • Voydeya
    Drug - 3 Dec 2024
    Consumer Medicine Information (CMI) about Voydeya intended for persons living in Australia.
  • Fluzone High-Dose QIV
    Drug - 27 Nov 2024
    Consumer Medicine Information (CMI) about Fluzone High-Dose QIV intended for persons living in Australia.
  • Vaxigrip Tetra
    Drug - 23 Nov 2024
    Consumer Medicine Information (CMI) about Vaxigrip Tetra intended for persons living in Australia.
  • Lipid-based nanoparticles: Manufacturing and inline size characterization
    White Paper - 6 Nov 2024
    Lipid-based nanoparticles have emerged as highly useful particles in the pharmaceutical industry. However, their manufacturing involves complex processes and in-process monitoring, such as inline size...
  • Toprol-XL
    Drug - 25 Oct 2024
    Consumer Medicine Information (CMI) about Toprol-XL intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback